Back to KI Korea Investment Corp
CRSP
5 quarters
Position history for KIKorea Investment Corp's holdings in CRISPR Therapeutics AG
No. Korea Investment exited its CRSP (CRISPR Therapeutics) position in Q4 2019. Its Q3 2019 13F listed 45,300 shares worth $1.9M. Korea Investment already held CRSP in its Q4 2018 13F, the earliest on record, and held it in 4 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1.4M
Total Shares Change
-47,900
Quarter-by-Quarter History
Other major holders of CRSP: ARK Investment Management LLC, Capital International Investors